Skip to main content
. 2015 Apr 23;6(19):17738–17752. doi: 10.18632/oncotarget.3921

Table 3. Mean values of liver function tests in Swiss mice hepatotoxicity model.

Group ALT(U/L) AST(U/L) UA(mg/dL) ALP(U/L) LDH(U/L) BUN(U/L) CRE(μmol/L) GLOB(mmol/L)
Control 28.22 ± 6.72 99.27 ± 11.44 286.4±64.6 218.51 ± 51.01 1542.05 ± 404.84 9.59 ± 1.14 17.87 ± 2.16 14.85 ± 0.25
Lapatinib 32.05 ± 5.57 99.59 ± 15.55 271.0±78.7 234.96 ± 54.33 1732.88 ± 489.41 10.95 ± 1.62 18.47 ± 2.19 14.1 ± 0.35
Paclitaxel 33.90 ± 6.09 97.94 ± 23.46 237.3±72.8 192.35 ± 32.12 1540.83 ± 457.35 9.82 ± 1.38 15.77 ± 1.78 14.12 ± 0.44
Paclitaxel + lapatinib 59.97 ± 26.72 * 107.10 ± 28.67 317.8±75.4 213.29 ± 53.45 1808.00 ± 610.33 10.23 ± 0.97 15.39 ± 1.85 * 17.95 ± 0.27
Doxorubicin 22.19±15.00 84.71±11.08 440.27±78.04 * 112.3±6.91 1606.32±505.09 7.91±0.82 20.17±7.14 18.74±1.83
Doxorubicin+ lapatinib 20.43±8.61 101.44±10.98 523.42±50.73 ** 113.85±18.66 1691.27±623.47 8.00±0.90 20.6±5.50 20.80±1.97 *

The P value was calculated by student t test. The values represent mean ± standard deviation in the triplicate determination.

*

P < 0.05

**

P < 0.01 for values versus those in control.